Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MYC | P01106 | 1/20 | 0.43 |
| ▸ | FTO | Q9C0B1 | 2/20 | 0.41 |
| ▸ | PRKAB2 | O43741 | 4/20 | 0.39 |
| ▸ | PRKAG1 | P54619 | 4/20 | 0.39 |
| ▸ | PRKAA2 | P54646 | 4/20 | 0.39 |
| ▸ | PRKAA1 | Q13131 | 4/20 | 0.39 |
| ▸ | PRKAG3 | Q9UGI9 | 4/20 | 0.39 |
| ▸ | PRKAG2 | Q9UGJ0 | 4/20 | 0.39 |
| ▸ | PRKAB1 | Q9Y478 | 4/20 | 0.39 |
| ▸ | RXRA | P19793 | 1/20 | 0.39 |
| ▸ | RXRB | P28702 | 1/20 | 0.39 |
| ▸ | AURKA | O14965 | 1/20 | 0.39 |
| ▸ | TPX2 | Q9ULW0 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.38 |
| ▸ | HNF4A | P41235 | 1/20 | 0.38 |
| ▸ | DHODH | Q02127 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29750762 | 0.85 | MAPK1 (0.37) | FTOCHRM1ACLYRORB | |
| SCHEMBL29750763 | 0.80 | MAPK14 (0.41) | RXRARXRBKMT2A | |
| SCHEMBL411720 | 0.80 | HNF4A (0.52) | MYCFTORXRARXRBKDM4E | |
| SCHEMBL29750758 | 0.70 | RXRA (0.42) | RXRARXRBALDH1A1DYRK1A | |
| SCHEMBL14037227 | 0.70 | MYC (0.47) | MYCFTOKDM4EUSP2ALDH1A1 | |
| SCHEMBL27544556 | 0.68 | MYC (0.52) | MYCAURKATPX2KDM4EUSP2 | |
| SCHEMBL23327330 | 0.68 | GPR35 (0.38) | MYCKDM4EALDH1A1DHODHACLY | |
| SCHEMBL269867 | 0.67 | HNF4A (0.53) | MYCKDM4EALDH1A1HNF4ACHRM1 | |
| SCHEMBL139845 | 0.67 | ALDH1A1 (0.59) | MYCKDM4EUSP2ALDH1A1TSHR | |
| SCHEMBL30047867 | 0.67 | ALDH1A1 (0.59) | MYCKDM4EUSP2ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210137884-A1 | INHIBITORS OF METALLO-BETA-LACTAMASES | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2021-05-13 | — | — | US | disclosed |
| EP-3630728-A1 | INHIBITORS OF METALLO-BETA-LACTAMASES | Oxford University Innovation Limited (GB) | 2020-04-08 | — | — | EP | disclosed |
| WO-2018215799-A1 | INHIBITORS OF METALLO-BETA-LACTAMASES | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2018-11-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210137884-A1 | INHIBITORS OF METALLO-BETA-LACTAMASES | MGAM, GAA, ALPI | MYC 1465/4885FTO 4176/4885PRKAB2 3260/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.